Additional Proxy Soliciting Materials (definitive) (defa14a)
13 Octobre 2022 - 10:17PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
14A
Proxy
Statement Pursuant to Section 14(a) of the
Securities
Exchange Act of 1934
(Amendment No. )
Filed
by the Registrant ☒
Filed
by a Party other than the Registrant ☐
Check
the appropriate box:
☐ |
Preliminary
Proxy Statement |
|
|
☐ |
Confidential,
for Use of the Commission Only (as Permitted by Rule
14a-6(e)(2)) |
|
|
☐ |
Definitive
Proxy Statement |
|
|
☒ |
Definitive
Additional Materials |
|
|
☐ |
Soliciting
Material under § 240.14a-12 |
AIM ImmunoTech Inc.
(Name
of Registrant as Specified in its Charter)
(Name
of Person(s) Filing Proxy Statement, if other than the
Registrant)
Payment
of Filing Fee (Check all boxes that apply):
☒ |
No
fee required |
|
|
☐ |
Fee
paid previously with preliminary materials |
|
|
☐ |
Fee
computed on table in exhibit required by Item 25(b) per Exchange
Act Rules 14a-6(i)(1) and 0-11 |
On
October 13, 2022, AIM ImmunoTech Inc. (the “Company” or “AIM”),
began mailing the attached letter to stockholders of the Company
asking them to vote to re-elect the members of the Company’s Board
of Directors.







AIM ImmunoTech (AMEX:AIM)
Graphique Historique de l'Action
De Jan 2023 à Fév 2023
AIM ImmunoTech (AMEX:AIM)
Graphique Historique de l'Action
De Fév 2022 à Fév 2023